Holen Sie sich die Stockscreener-App
7.46
2.47%
0.18
Vorhandelsmarkt:
7.44
-0.02
-0.27%
Organon Co Aktie (OGN) Neueste Nachrichten
5 Revealing Analyst Questions From Organon’s Q4 Earnings Call - Yahoo Finance UK
Organon & Co. (OGN) Stock Analysis: Evaluating a Potential 24.69% Upside in the Healthcare Sector - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Trading Systems Reacting to (OGN) Volatility - Stock Traders Daily
Organon (OGN) Is Down 10.0% After Earnings Miss And Cautious 2026 OutlookHas The Bull Case Changed? - simplywall.st
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know - Finviz
BofA Securities Maintains Organon & Co(OGN.US) With Sell Rating - 富途牛牛
Organon (OGN) Is Down 12.8% After Earnings Miss And Flat 2026 Outlook Has The Bull Case Changed? - Yahoo Finance
OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook - Finviz
Organon & Co. Plans Quarterly Dividend of $0.02 (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Q4 2025 Earnings Call Transcript - Insider Monkey
Assessing Organon (OGN) Valuation After Earnings Miss And Flat 2026 Revenue Guidance - Yahoo Finance
LSV Asset Management Has $83.67 Million Holdings in Organon & Co. $OGN - MarketBeat
Organon Co earnings missed by $0.13, revenue fell short of estimates - Investing.com South Africa
Organon Reshapes Women’s Health Focus With Nexplanon Shift And Jada Sale - Yahoo Finance
Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss By Investing.com - Investing.com South Africa
Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss - Investing.com Canada
Organon & Co. Q4 Earnings Call Highlights - MarketBeat
Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations - The Globe and Mail
Organon & Co To Go Ex-Dividend On February 23rd, 2026 With 0.02 USD Dividend Per Share - 富途牛牛
Organon Earnings Call Balances Stability With Rising Risks - TipRanks
Organon Q3 Net Margin Squeeze Challenges Bullish Earnings Growth Narratives - simplywall.st
Organon & Co. Q4 2025 Earnings Call Summary - Yahoo Finance
Organon Shares Slide on Quarterly Loss and Cautious Outlook - AD HOC NEWS
Organon (OGN) Q4 2025 Earnings Call Transcript - The Globe and Mail
Organon & Co. (NYSE:OGN) Issues Earnings Results - MarketBeat
Organon: Overview of Fourth Quarter Financial Results - Bitget
Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Investors to Inquire about Securities Investigation - ACCESS Newswire
Organon Q4 Earnings ReviewPoor Results Trigger Predictable Sell-Off (NYSE:OGN) - Seeking Alpha
Organon sees FY26 revenue $6.2B, consensus $6.11B - TipRanks
Organon outlines flat $6.2B revenue and $1.9B EBITDA targets for 2026 as cost controls and portfolio shifts take center stage - MSN
Organon reports Q4 adjusted EPS 63c, consensus 73c - TipRanks
Organon Shares Fall After 4Q Earnings Miss Expectations - 富途牛牛
Organon & Co. (NYSE:OGN) Shares Gap Down Following Weak Earnings - MarketBeat
Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
OGN: 2025 results show stable revenue and EBITDA, with 2026 guidance flat amid margin and policy headwinds - TradingView
Organon Co earnings missed by $0.13, revenue fell short of estimates By Investing.com - Investing.com Canada
Earnings call transcript: Organon Q4 2025 reveals EPS miss, stock drops 10.8% - Investing.com
Organon (OGN) Misses Q4 Earnings and Revenue Estimates - Yahoo Finance
Organon falls as women’s health unit drives Q4 miss (OGN:NYSE) - Seeking Alpha
Organon: Q4 Earnings Snapshot - kare11.com
Organon Q4 Adjusted Earnings, Revenue Fall; 2026 Revenue Outlook Issued - 富途牛牛
Earnings snapshot: Organon & Co. misses bottom-line estimates; initiates FY26 outlook - MSN
Organon & Co (NYSE:OGN) Shares Drop on Q4 Earnings Miss and Flat 2026 Outlook - ChartMill
(OGN) Organon Expects 2026 Revenue About $6.22B, vs. FactSet Est of $6.11B - marketscreener.com
Earnings Flash (OGN) Organon Posts Q4 Revenue $1.51B, vs. FactSet Est of $1.54B - marketscreener.com
Earnings Flash (OGN) Organon Posts Q4 Adjusted EPS $0.63, vs. FactSet Est of $0.73 - marketscreener.com
Organon shares fall over 5% as Q4 earnings miss expectations By Investing.com - Investing.com South Africa
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 - Business Wire
0.00%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):